Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00580008 · ClinicalTrials.gov registry record

Evaluation Using Computed Tomography Angiography (CTA) to Investigate and Detect Atherosclerotic Graft Disease (ELUCIDATE)

A clinical trial of Coronary Artery Disease and Arteriosclerosis of Coronary Artery Bypass Graft, sponsored by Corewell Health East.

Completed
Registry status
178
Enrollment target
1
Study location

NCT00580008 is a study of Coronary Artery Disease and Arteriosclerosis of Coronary Artery Bypass Graft that has completed, run by Corewell Health East. The registered enrollment target is 178 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00580008, a study of Coronary Artery Disease and Arteriosclerosis of Coronary Artery Bypass Graft, has completed, sponsored by Corewell Health East.

COMPLETED
Registry status
178 participants
Enrollment target
1
Study location

Study Summary

The purpose of clinical research is to look at the nature of disease and try to develop improved methods to diagnose and treat disease.The goal of this study is to evaluate the use of computed tomography (CT) scan of the heart in the diagnosis of disease in vein grafts after bypass surgery.

Study Locations (1)

Michigan

  • William Beaumont Hospital - Royal Oak

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2007-12
Est. Completion 2011-08

Sponsor

Corewell Health East

106 total trials

What the Registry Record Tells You About NCT00580008

The ClinicalTrials.gov registry entry for NCT00580008 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (86% lower). The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT00580008 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT00580008 about?

NCT00580008 is a clinical study titled "Evaluation Using Computed Tomography Angiography (CTA) to Investigate and Detect Atherosclerotic Graft Disease (ELUCIDATE)". The purpose of clinical research is to look at the nature of disease and try to develop improved methods to diagnose and treat disease.The goal of this study is to evaluate the use of computed tomography (CT) scan of the heart in the diagnosis of disease in vein grafts after bypass surgery.

What is the current status of trial NCT00580008?

This trial is currently completed. The enrollment target is 178 participants. The study started on 2007-12. Estimated completion is 2011-08.

What conditions does trial NCT00580008 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Arteriosclerosis of Coronary Artery Bypass Graft.

Who is sponsoring clinical trial NCT00580008?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00580008 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.